{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T18:35:36Z","timestamp":1788201336330,"version":"build-2803163510"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,6,15]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To evaluate health-care utilization and costs attributable to herpes zoster (HZ) within a population of patients with solid organ transplant (SOT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using administrative claims data, a commercially\/Medicare-insured population of patients with SOT between January 1, 1999, and January 1, 2007, and a Medicaid population between January 1, 1999, and January 1, 2006, were identified. Each patient group was screened to select patients with claims of SOT with an incident diagnosis of HZ and continuous enrollment for the 6 months prior and 3 months subsequent to the incident HZ. Controls were selected from group of SOT patients without claims of HZ using a propensity score matching process. Descriptive analyses were performed to quantify health-care utilization and costs attributable to HZ. Multivariate analyses were used to estimate HZ-attributable costs adjusted by demographic and clinical variables.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 205 commercially\/Medicare-insured matched pairs and 136 Medicaid matched pairs were selected. Mean age in the commercial\/Medicare SOT-HZ population was 56.9 years, and that in the Medicaid population was 42.5 years. The majority of HZ patients were diagnosed within 2 years of evidence of SOT. The unadjusted differences in total HZ-attributable health-care costs were $4762 and $6705 for commercial\/Medicare-insured and Medicaid patients, respectively (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.176 and\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.003, respectively) and were largely driven by hospitalization costs. Adjusted incremental costs in the SOT-HZ commercial\/Medicare-insured patients were $5335 (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.001), and that in noncapitated Medicaid patients were $3711 (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The occurrence of HZ in patients immunocompromised by SOT significantly increased health-care utilization and costs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/01.tp.0000441826.70687.f6","type":"journal-article","created":{"date-parts":[[2014,1,20]],"date-time":"2014-01-20T06:06:57Z","timestamp":1390198017000},"page":"1178-1184","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":24,"title":["Herpes Zoster-Attributable Resource Utilization and Cost Burden in Patients With Solid Organ Transplant"],"prefix":"10.1097","volume":"97","author":[{"given":"Liisa","family":"Palmer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald R.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara H.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilo J.","family":"Acosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20260831","first-page":"1","article-title":"Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"57","year":"2008","journal-title":"MMWR Recomm Rep"},{"key":"R2-17-20260831","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/j.1525-1497.2005.0150.x","article-title":"The incidence of herpes zoster in a United States administrative database.","volume":"20","author":"Insinga","year":"2005","journal-title":"J Gen Intern Med"},{"key":"R4-17-20260831","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1046\/j.1600-6143.2003.00287.x","article-title":"Herpes zoster infection following solid organ transplantation: incidence, risk factors and outcomes in the current immunosuppressive era.","volume":"4","author":"Gourishandar","year":"2004","journal-title":"Am J Transplant"},{"key":"R5-17-20260831","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/infdis\/135.4.659","article-title":"A longitudinal study of varicella-zoster virus infections in renal transplant recipients.","volume":"135","author":"Luby","year":"1977","journal-title":"J Infect Dis"},{"key":"R6-17-20260831","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1056\/NEJM197706162962402","article-title":"Cellular immunity and herpes virus infections in cardiac-transplant patients.","volume":"296","author":"Rand","year":"1977","journal-title":"N Engl J Med"},{"key":"R7-17-20260831","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2165\/11317560-000000000-00000","article-title":"Incremental 1-year medical resource utilization and costs for patients with herpes zoster from a set of US health plans.","volume":"27","author":"White","year":"2009","journal-title":"Pharmacoeconomics"},{"key":"R8-17-20260831","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2165\/00019053-200725020-00007","article-title":"Acutesubacute herpes zoster. Healthcare resource utilisation and costs in a group of US health plans.","volume":"25","author":"Insinga","year":"2007","journal-title":"Pharmacoeconomics"},{"key":"R9-17-20260831","first-page":"48","article-title":"A descriptive analysis of 1251 solid organ transplant visits to the emergency department.","volume":"10","author":"Unterman","year":"2009","journal-title":"West JEM"},{"key":"R10-17-20260831","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/AJP.0b013e3181eef686","article-title":"A prospective study of the herpes zoster severity of illness.","volume":"26","author":"Drolet","year":"2010","journal-title":"Clin J Pain"},{"key":"R11-17-20260831","doi-asserted-by":"crossref","first-page":"787","DOI":"10.4065\/84.9.787","article-title":"Health care utilization and cost burden of herpes zoster in a community population.","volume":"84","author":"Yawn","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"R12-17-20260831","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/j.1532-5415.2007.01231.x","article-title":"Healthcare costs of acute and chronic pain associated with a diagnosis of herpes zoster.","volume":"55","author":"Dworkin","year":"2007","journal-title":"JAGS"},{"key":"R13-17-20260831","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3109\/13814789609161651","article-title":"The clinical course of herpes zoster: a prospective study in primary care.","volume":"2","author":"Helgason","year":"1996","journal-title":"Eur J Gen Pract"},{"key":"R14-17-20260831","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.vaccine.2005.09.026","article-title":"The burden of herpes zoster: a prospective population based study.","volume":"24","author":"Scott","year":"2006","journal-title":"Vaccine"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00007890-201406150-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T18:00:12Z","timestamp":1788199212000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007890-201406150-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,15]]},"references-count":13,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/01.tp.0000441826.70687.f6","relation":{},"ISSN":["0041-1337","1534-6080"],"issn-type":[{"value":"0041-1337","type":"print"},{"value":"1534-6080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,15]]}}}